CoChat

Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Myostatin is a protein synthesized and secreted by skeletal muscle that negatively regulates muscle mass. The extent to which circulating myostatin levels change in the context of aging is controversial, largely due to methodological barriers. METHODS: We developed a specific and sensitive liquid chromatography with tandem mass spectrometry (LC-MS/MS) assay to measure concentrations of myostatin and two of its key inhibitors, follistatin-related gene (FLRG) protein and growth and serum protein-1 (GASP-1) in 80 younger (<40 years), 80 older (>65 years), and 80 sarcopenic older women and men. RESULTS: Older women had 34 % higher circulating concentrations of myostatin than younger women. Per unit of lean mass, both older and sarcopenic older women had >23 % higher myostatin levels than younger women. By contrast, younger men had higher myostatin concentrations than older men with and without sarcopenia. Younger men had approximately twofold higher concentrations of myostatin than younger women; however, older women and sarcopenic older women had significantly higher relative myostatin levels than the corresponding groups of men. In both sexes, sarcopenic older subjects had the highest concentrations of FLRG. Circulating concentrations of myostatin exhibited positive, but not robust, correlations with relative muscle mass in both sexes. CONCLUSIONS: Our data suggest that myostatin may contribute to the higher prevalence of sarcopenia in women but acts as a homeostatic regulator of muscle mass in men. Moreover, this new LC-MS/MS-based approach offers a means to determine the extent to which myostatin serves as a biomarker of muscle health in diverse conditions of muscle loss and deterioration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13395-015-0047-5

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Calibration curves for LC-MS/MS measures of myostatin, propeptide, GASP-1, and FLRG. Linear calibration curves for recombinant intact myostatin (a), propeptide (b), GASP-1 (c), and FLRG (d) diluted into bovine serum albumin over a concentration range of 0.031 to 1.00 nM
Fig. 1 Calibration curves for LC-MS/MS measures of myostatin, propeptide, GASP-1, and FLRG. Linear calibration curves for recombinant intact myostatin (a), propeptide (b), GASP-1 (c), and FLRG (d) diluted into bovine serum albumin over a concentration range of 0.031 to 1.00 nMCC BY · PubMed Central
Fig. 2 Circulating myostatin and propeptide levels by LC-MS/MS in younger and older women and men. Box plots (25–75 percentile) and whiskers (Tukey method) comparing serum concentrations of a myostatin, b myostatin relative to total body lean mass (TBLM), c propeptide, and d propeptide relative to TBLM between younger women (YW), older women (OW), and sarcopenic older women (SOW). Comparisons of circulating concentrations of absolute and relative concentrations of myostatin and propeptide between corresponding groups of men are also illustrated (e-h). *, **, and *** denote p < 0.05, 0.01, and 0.001, respectively, compared to the younger group except when denoted with a bracket
Fig. 2 Circulating myostatin and propeptide levels by LC-MS/MS in younger and older women and men. Box plots (25–75 percentile) and whiskers (Tukey method) comparing serum concentrations of a myostatin, b myostatin relative to total body lean mass (TBLM), c propeptide, and d propeptide relative to TBLM between younger women (YW), older women (OW), and sarcopenic older women (SOW). Comparisons of circulating concentrations of absolute and relative concentrations of myostatin and propeptide between corresponding groups of men are also illustrated (e-h). *, **, and *** denote p < 0.05, 0.01, and 0.001, respectively, compared to the younger group except when denoted with a bracketCC BY · PubMed Central
Fig. 3 Circulating FLRG and GASP-1 concentrations by LC-MS/MS in younger and older women and men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a FLRG, b GASP-1, c FLRG relative to myostatin, and d GASP-1 relative to myostatin between younger women (YW), older women (OW) and sarcopenic older women (SOW). Comparisons of myostatin inhibitors and their ratios to myostatin between corresponding groups of men are also illustrated (e-h). *, **, and *** denote p < 0.05, 0.01, and 0.001, respectively, compared to the younger group except when denoted with a bracket
Fig. 3 Circulating FLRG and GASP-1 concentrations by LC-MS/MS in younger and older women and men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a FLRG, b GASP-1, c FLRG relative to myostatin, and d GASP-1 relative to myostatin between younger women (YW), older women (OW) and sarcopenic older women (SOW). Comparisons of myostatin inhibitors and their ratios to myostatin between corresponding groups of men are also illustrated (e-h). *, **, and *** denote p < 0.05, 0.01, and 0.001, respectively, compared to the younger group except when denoted with a bracketCC BY · PubMed Central
Fig. 4 Circulating myostatin and propeptide levels in women compared to men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a myostatin, b myostatin relative to total body lean mass (TBLM), c propeptide, and d propeptide relative to TBLM between younger women (YW) and younger men (YM) (top panel), older women (OW) and older men (OM) (middle panel), and sarcopenic OW (SOW) and sarcopenic OM (SOM) (bottom panel). * and *** denote p < 0.05 and 0.001, respectively
Fig. 4 Circulating myostatin and propeptide levels in women compared to men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a myostatin, b myostatin relative to total body lean mass (TBLM), c propeptide, and d propeptide relative to TBLM between younger women (YW) and younger men (YM) (top panel), older women (OW) and older men (OM) (middle panel), and sarcopenic OW (SOW) and sarcopenic OM (SOM) (bottom panel). * and *** denote p < 0.05 and 0.001, respectivelyCC BY · PubMed Central
Fig. 5 Circulating FLRG and GASP-1 concentrations in women compared to men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a FLRG, b GASP-1, c FLRG relative to myostatin, and d GASP-1 relative to myostatin between younger women (YW) and younger men (YM) (top panel), older women (OW) and older men (OM) (middle panel), and sarcopenic OW (SOW) and sarcopenic OM (SOM) (bottom panel). *** denotes p < 0.001
Fig. 5 Circulating FLRG and GASP-1 concentrations in women compared to men. Box plots (25–75 percentile) and whiskers (Tukey method) showing comparisons of a FLRG, b GASP-1, c FLRG relative to myostatin, and d GASP-1 relative to myostatin between younger women (YW) and younger men (YM) (top panel), older women (OW) and older men (OM) (middle panel), and sarcopenic OW (SOW) and sarcopenic OM (SOM) (bottom panel). *** denotes p < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. White TA, Lebrasseur NK. Myostatin and sarcopenia: opportunities and challenges—a mini-review. Gerontology. 2014. doi:10.1159/000356740. · DOI · Paper page

Cited by

See all 137

Metadata

Authors
Bergen, H. R., Farr, J. N., Vanderboom, P. M., Atkinson, E. J., White, T. A., Singh, R. J., Khosla, S., & LeBrasseur, N. K.
Affiliations
Mayo Clinic (US)
Corresponding author
LeBrasseur, Nathan K.
Venue
Skeletal Muscle
Published
2015-07-15
Volume
5
Issue
1
Pages
21-21
ISSN
2044-5040 (ISSN-L)
OpenAlex
W2119826306
Cited by
137
References
43
Citations by year
2026: 10 · 2025: 12 · 2024: 16 · 2023: 21 · 2022: 17 · 2021: 11 · 2020: 8 · 2019: 16 · 2018: 14 · 2017: 4 · 2016: 7 · 2015: 1
FWCI
3.77
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Skeletal Muscle (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000135, AG004875, AR027065, TR000135)
  • Center for Clinical and Translational Science, Mayo Clinic (UL1‐TR000135, TR000135)
  • National Institute on Aging (P01AG004875)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-027065, R01AR027065)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences (AR027065, TR000135)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
myostatin, sarcopenia, aging, sex differences, older adults

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. https://app.cochat.ai/papers/10.1186/s13395-015-0047-5
The paper
Bergen, H. R., Farr, J. N., Vanderboom, P. M., Atkinson, E. J., White, T. A., Singh, R. J., Khosla, S., & LeBrasseur, N. K. (2015). Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skeletal Muscle. https://doi.org/10.1186/s13395-015-0047-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.